Contact Us

Optimizing the potential commercial of products 

Catalyst Pharmaceutical Research

About Us

Catalyst Pharmaceutical Research (CPR) is an integrated clinical research organization providing high-quality clinical research, biostatistics and data processing, regulatory, and licensing services support for pharmaceutical development.

CPR's experienced staff applies industry proven information technology systems for rapid and reliable trial management, and electronic data capture and analysis, for Phase II and III multi-center international studies. This speeds project timelines, and reduces our clients overall development costs, while ensuring the highest level of security, accuracy and reliability.

Recent News

  • [03/13/06] Nissan Chemical Reports Positive Phase IIb study results for NM-702 in Intermittent Claudication »
  • [09/21/04] aRigen, Japanese Bioventure Company, Announces Start of US Clinical Study of Novel Anti-Staph Antibiotic By Catalyst (CRO) »
  • [09/03/04] OmniComm Systems (TrialMaster®) and Catalyst Pharmaceutical Research Team-Up to Expedite Phase I Trial Data Collection and Reporting »